PRIMARY STUDY
Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management
Key Findings: The authors concluded that there was insufficient evidence to prescribe cannabis use as a therapeutic agent for management of urological cancers.
Type of Study: Meta-analysis
Study Result: Inconclusive
Research Location(s): Canada
Year of Pub: 2021
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: Taneja S, et al. Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management. Can Urol Assoc J. 2021; 15:413-419. doi: 10.5489/cuaj.7198
Authors: Taneja S, Hoogenes J, Slaven M, Kapoor A
